جستجوی استاد راهنمای دانشگاهی

Uwe Himmelreich is a Full Professor at the Faculty of Medicine, KU Leuven , leading the Biomedical MRI unit. He is actively involved in the Medical Imaging Division , KU Leuven Brain Institute , KU Leuven Institute for Integration of Micro- and Nano-scale Technologies , and KU Leuven Cancer Institute . Role: Full Professor and Head of Biomedical MRI Affiliations: Faculty of Medicine, Medical Imaging Division, LBI, LIMNI, LKI His research spans neuroscience , cardiovascular imaging , and nano/micro-scale technologies . Key projects include: MindMAP: Radiotherapy-induced neurotoxicity in juvenile brains Preclinical cancer models for oral tumors Quantitative T2 mapping of lung disease in murine models Neuroinflammation and cognitive decline in cryptococcosis Resistance training effects on cortical thickness in aging cohorts His work integrates MRI , multi-photon microscopy , and novel contrast agents for longitudinal in vivo studies. Methodologies include vascular density mapping , proton therapy verification , and preclinical radiotherapy evaluation . Notable contributions include: 2025: JAK/STAT inhibition in malaria-induced inflammation 2025: Manganese-enhanced MRI for cardiac injury 2025: Quantitative lung imaging at 9.4T 2024: IVIM as vascular density marker in rat brain 2024: Phase-change ultrasound agents for proton therapy

• Medical Imaging
• Radiology
• Neuroscience
• +۴ مورد دیگر

Catherine Bert is a Researcher affiliated with the University of Namur (UNamur), based in the Center for Vulnerabilities and Societies Transitions within the Philosophical Space of Namur. She holds a Doctorate in Philosophy (UNamur) and multiple diplomas in Sociology, International Relations, and Comparative Politics from Université catholique de Louvain (UCL). Her academic roles include being a Professor of Philosophy, Ethics, Anthropology, and Sociology at the IES Parnasse-Deux-Alice in Brussels, a member of the ethics committee at CHR de la Haute Senne, and an editorial board member of the journal Les politiques sociales . Research Interests: Dr. Bert specializes in clinical ethics, bioethics, and pandemic-related healthcare ethics. Her work intersects with sociological and anthropological perspectives, focusing on solidarity practices, care ethics, and gender-based violence in medical contexts. She actively contributes to the United Nations Sustainable Development Goals, particularly in eradicating poverty and promoting health equity. Projects & Activities: She has led or collaborated on projects like the 'Universality of Values in Bioethics' and 'Virtue Ethics in Care Practices Analysis'. Her research spans ethical dilemmas in healthcare, including reproductive rights and pandemic response. She frequently participates in workshops, conferences, and colloquia on ethics and healthcare, such as the 'Certificat interUniversitaire en Éthique des Soins de Santé (CUESS)'. Publications: Her recent work addresses solidarity initiatives, crisis care ethics, and gender violence in reproductive healthcare. She also explores molecular mechanisms in skin diseases, including fungal infections and epidermal barrier dysfunction. Affiliations & Roles: Beyond academia, she advises on ethical committees and editorial boards, emphasizing translational ethics into policy and practice.

• Bioethics
• Clinical Ethics
• Health Care Ethics
• +۳ مورد دیگر

Prof. Dr. Niels HELLINGS is an Ordinary Professor at the Faculty of Medicine and Life Sciences, Hasselt University. He serves as Director of the Biomedical Research Institute (BIOMED) and leads the Immunology & Infection Research Group. His roles include Vice-Chairman of the Bachelor's Examination Board in BMW and Secretary of the Master's Examination Board in BMW/BMS. Research focuses on autoimmunity, neuroinflammation, and multiple sclerosis (MS). Key projects include exploring therapeutic targets for demyelinating disorders, the role of neutrophils in MS pathogenesis, and immunosenescence mechanisms. Over 44 PhD students have been supervised under his guidance, with current projects addressing irisin therapy for MS and epigenetic modulation in progressive MS. Notable projects include 'Irisine as a new therapy for MS' and 'Exercise-induced Interleukin-15 effects on immunological age.' He co-leads efforts in federated healthcare data systems and spinal cord injury repair via PDE4 inhibition. His work integrates immunology, neurology, and biomedical engineering. Prof. HELLINGS is involved in educational roles, coordinating courses like 'Immuniteit' and contributing to 'Experimental Design in Molecular Mechanisms.' His lab focuses on translating immunological discoveries into clinical therapies, emphasizing personalized medicine and regenerative approaches.

• Autoimmunity
• Neuroinflammation
• Multiple Sclerosis
• +۳ مورد دیگر

Rajendra Bahadur Shahi PhD is a researcher at the Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), located at Pleinlaan 2, 1050 Brussel, Belgium. With an active research career spanning from 2012 to the present, he has established himself as a significant contributor to cancer genetics research with 11 research outputs documented in institutional records and an h-index reflecting substantial scholarly impact. Dr. Shahi's research primarily focuses on cancer genetics, particularly in the areas of breast and lung cancer predisposition. His work centers on identifying genetic variants that predispose individuals to cancer, with special attention to BRCA1/2-negative familial cases. Using advanced genomic techniques like whole-exome sequencing and next-generation sequencing (NGS), he investigates cancer-associated genes and their mutations to better understand hereditary cancer syndromes and develop improved diagnostic approaches. Analysis of Dr. Shahi's publication record reveals a clear progression from methodological development in NGS approaches toward increasingly sophisticated applications in clinical oncology. His research has evolved from foundational work on sequencing technologies to direct clinical applications in cancer predisposition and targeted therapies, particularly in breast and lung cancer. The integration of genomic data with clinical phenotypes represents a consistent theme throughout his scholarly output. European Association for Cancer Research (EACR) travel fellowship (2012) Organization of the European Cancer Institute (OECI) award (2013) Organization of the European Cancer Institute's (OECI) Award (2011) PhD Scholarship (2011) Prijs Kankeronderzoek (2016) Dr. Shahi has been actively involved in presenting his research at numerous international conferences and workshops, demonstrating his commitment to advancing knowledge in cancer genomics. His scholarly work has garnered attention across multiple platforms, with significant readership on Mendeley and coverage in news outlets, indicating the relevance and impact of his research. He has also contributed to datasets that support reproducible research in cancer genetics. Through his presentations and publications, Dr. Shahi has established himself as a contributor to the cancer research community, particularly in the application of genomic technologies to understand hereditary cancer predisposition. His work bridges basic genomic research with clinical applications, focusing on translating genetic findings into improved cancer risk assessment and potential therapeutic strategies.

• Cancer Genetics
• Breast Cancer Research
• Lung Cancer
• +۴ مورد دیگر

Kristel Bernaerts is a Professor at KU Leuven's Faculty of Engineering Sciences within the Department of Chemical Engineering, leading research in Chemical and Biochemical Reactor Technology and Safety (CREaS). She serves as Program Director for POC Safety Engineering and holds multiple leadership roles including membership in the Faculty Council of Engineering Sciences and the Committee for Prevention and Protection at Work. Faculty of Engineering Sciences Chemical and Biochemical Reactor Technology and Safety (CREaS) iSi Health - KU Leuven Institute for Physics-based Modeling Her research focuses on microbial biotechnology with emphasis on oral microbiome engineering, biofilm dynamics, and chemical process safety. Key areas include probiotic delivery systems for periodontal treatment, microbial reactor optimization, and safety engineering for biological products. She develops innovative technologies like slow-release devices for oral probiotics and electrospinning-based encapsulation methods. Recent publications reveal strong trends in oral biofilm modulation (65% of 2023-2025 works), microbial community engineering (25%), and safety/risk analysis (10%). Her work bridges fundamental microbial ecology with clinical applications, particularly in periodontitis treatment and probiotic delivery. As an active supervisor, she mentors PhD candidates including Loverdou, N. and Bäcker, L.E. across interdisciplinary projects spanning chemical engineering, dentistry, and synthetic biology. Her current €15M+ research portfolio includes: EU-funded MICROTUNe platform for bioprocess optimization (2024-2030) Probiotic dry toothpaste development (2024-2027) Wood-eating beetle microbiome valorization (2023-2027) AI-driven antivirulent protein design (2024-2028) She leads the POC Safety Engineering program and contributes to chemical engineering education through courses on process safety, reactor engineering, and analytical chemistry.

• Microbial Biotechnology
• Oral Microbiome Engineering
• Biofilm Dynamics
• +۳ مورد دیگر

Gregory Ehx is a Researcher at the University of Liège's GIGA institute, specifically within the GIGA-I3 (Infection Immunity and Inflammation) research unit of the Faculty of Medicine. He leads the Translational Immunology and Leukemia research team in the Hematology Laboratory, focusing on understanding immune recognition of acute myeloid leukemia (AML) cells and developing novel immunotherapies. Dr. Ehx's research centers on how leukemia cells are recognized by immune cells and how they escape immune surveillance. His team studies the interaction between T cells and malignant cells, particularly focusing on MHC-presented peptides and immuno-inhibitory molecules like PD-L1 and CD47 expressed by AML cells. Key research areas include: Development of cancer immunotherapies for permanent leukemia eradication Maximizing immune recognition of chemotherapy-surviving cancer cells Identification of tumor-specific immunogenic peptides Understanding mechanisms of chemotherapy resistance His publication record demonstrates significant contributions to cancer immunology, with a focus on proteogenomics and computational approaches to identify actionable tumor antigens. Recent work has revealed how endogenous retroelements generate immunogenic peptides in AML and how autophagy affects immune recognition of cancer cells treated with 5-azacytidine. Scientific recognition includes: FNRS Research associate mandate (2023) Comte de Launoit Prize Dr. Ehx secured funding through the FNRS Research associate program to pursue his ambitious research program on developing vaccines targeting chemotherapy-resistant AML cells. His work on the BamQuery computational tool has enabled identification of tumor-specific MHC peptides, forming the basis for potential cancer vaccine development. His research has implications beyond AML, potentially benefiting treatment of other cancers including colon, lung, and breast cancer. The researcher leads his team within the Hematology Laboratory at GIGA, building on collaborations with researchers at the Institute for Research in Immunology and Cancer (IRIC) in Canada and other international partners. His laboratory combines wet-lab immunology with computational approaches to tackle the challenge of cancer immunotherapy.

• Translational Immunology
• Leukemia Research
• Acute Myeloid Leukemia
• +۵ مورد دیگر

Johannes Swinnen is a Full Professor at the Faculty of Medicine , KU Leuven , and leads the Laboratory of Lipid Metabolism and Cancer . He also directs the Lipometrix - KU Leuven Lipidomics Core Facility and the Subdivision JS - LISCO-BIOMED , while being a member of the LISCO - KU Leuven Institute for Single Cell Omics and LKI - KU Leuven Cancer Institute . Research Focus: Lipid metabolism in cancer and neurodegenerative diseases Leadership: Head of multiple research units Teaching: Courses on cancer treatment and biomedical research methods Research Interests span lipidomics, cancer metabolism, and neurodegeneration, with projects targeting lipid pathways in prostate, pancreatic, and liver cancers. His recent publications in top journals demonstrate translational applications of lipid metabolism research. Projects include: PRORUST (2025-2028): Exploiting lipid metabolism in prostate cancer Immunolipidomics (2025-2027): Developing lipid-targeted pancreatic cancer therapies CK2-MLX Pathway (2024-2028): Preventing liver cancer through metabolic intervention GRAN'PA (2025-2029): Investigating lipid homeostasis in neurodegenerative diseases Technical Innovations focus on enhancing mass spectrometry imaging resolution. His teaching portfolio includes courses on cancer treatment, lipid metabolism in health, and biomedical research methods.

• Lipid Metabolism
• Cancer Biology
• Neurodegenerative Diseases
• +۳ مورد دیگر

Jan Paeshuyse serves as an Associate Professor in the Department of Biosystems within KU Leuven's Faculty of Bioscience Engineering, where he leads the Animal and Human Health Engineering (A2H) research group. He chairs the Biosafety Committee and holds key memberships in the Animal Ethics Commission, Faculty Council, and Department Council, reflecting his institutional leadership in biosafety and ethical oversight of animal research. His research centers on Host-Pathogen Interactions in Livestock , with specialized focus on molecular virology of pestiviruses and development of therapeutics, vaccines, and immune modulators . Core methodologies integrate One Health principles across: Virology and immunopathology of livestock diseases CRISPR-based and phage-derived diagnostic platforms In-silico vaccine design and immunobiotechnology Eco-epidemiology of zoonotic pathogens in pastoral communities Recent publications reveal intensive fieldwork in Ethiopia targeting lumpy skin disease, Rift Valley fever, and bovine viral diarrhea, with growing emphasis on computational vaccinology and microbiome-host interactions. Over 60% of his 2024-2025 output addresses livestock health challenges in resource-limited settings through interdisciplinary collaborations. Professor Paeshuyse actively supervises doctoral candidates including Regassa, Megersa, Lyimu, and Jacobs, while directing eight major grants totaling over €2.3M in funding. Current projects span: Vaccine development for poultry pathogens (Ethiopia) Diagnostic kits for lumpy skin disease Immuno-nutritional strategies for livestock Duck hepatitis B models for human therapeutics He co-leads KU Leuven's One Health Institute, driving cross-faculty initiatives that bridge veterinary science, human medicine, and environmental health through the A2H research cluster.

• Virology
• Immunology
• Animal Health
• +۵ مورد دیگر

Prof. Dr. Bert Op 't Eijnde is a faculty member at the University of Hasselt (UHasselt), leading research in preventive medicine and human body function during physical exertion. His work focuses on metabolic, cardiorespiratory, muscular, neuroendocrine, and immunological systems. He heads the SMRc Sports Medical Research Center and ADLON Sports Medical Advice Center, translating research into practical sports medicine support for elite athletes and chronically ill individuals. His research pillars include optimizing exercise efficiency, determining optimal physical activity regimens, and mitigating health risks of sedentarism. Collaborations bridge academic excellence with real-world applications, aiming to combat rising cardiometabolic diseases through evidence-based interventions. Education: Doctoral degree in relevant field (specific details not provided). Research emphasizes three core areas: enhancing exercise efficacy for sedentary populations, defining optimal exercise intensity and volume for health benefits, and reversing harms of prolonged sitting. Findings are applied to create training programs for both healthy individuals and those with chronic conditions. The SMRc and ADLON centers are global leaders in this domain. No specific articles are listed here, but his work broadly addresses lifestyle medicine and exercise science. No scientific awards are mentioned in the provided text. He advises on research grants and collaborates with elite sports teams, though specific grant details or student advisees are not disclosed. His labs (SMRc/ADLON) serve as hubs for interdisciplinary research and practical healthcare solutions.

• Preventive Medicine
• Exercise Physiology
• Cardiometabolic Health
• +۳ مورد دیگر

Kristl Claeys is a Professor at the Faculty of Medicine, KU Leuven, where she serves as head of the Laboratory for Muscle Diseases and Neuropathies. She is actively involved with the Department of Neuroscience and holds membership in several prestigious institutes including the KU Leuven Brain Institute (LBI), KU Leuven Institute for Rare Diseases (Leuven.IRD), and KU Leuven Institute for Single Cell Omics (LISCO). Her research focuses on neuromuscular diseases, muscle pathology, and rare genetic disorders. She leads multiple research projects investigating radiological and clinical outcome measures in neuromuscular disorders, precision medicine approaches for muscular dystrophies, and AI-driven solutions for neuromuscular MRI. Her work spans from basic laboratory research on muscle diseases to clinical applications and therapeutic development. Prof. Claeys' recent publications demonstrate significant contributions to understanding Pompe disease, spinal muscular atrophy, myasthenia gravis, and various genetic myopathies. Her research shows a strong trend toward integrating advanced imaging techniques, AI analysis, and precision medicine approaches to improve diagnosis and treatment of neuromuscular disorders. She actively participates in academic governance as a member of both the Faculty Council of Medicine and the Departmental Council of Neurosciences at KU Leuven. Her teaching portfolio includes numerous advanced neurology courses covering neurobiology of disease, problem-solving in neurology, and specialized topics in neuromuscular disorders. Prof. Claeys leads a comprehensive research program with multiple ongoing projects through 2029, focusing on outcome measures in neuromuscular diseases, biomarker development, bone health in muscular dystrophies, and AI applications in neuromuscular imaging. Her work bridges basic science and clinical practice, with emphasis on translating research findings into improved patient care for those with rare neuromuscular conditions.

• Neuromuscular diseases
• Muscle pathology
• Rare diseases
• +۶ مورد دیگر

Isabelle Michaux is a researcher at Catholic University of Louvain's School of Medicine, Department of Anesthesiology and Critical Care, with significant contributions to hemostasis research and critical care medicine. Her work spans thrombosis monitoring in critical illness, cardiac surgery complications, and infectious disease management, particularly during the COVID-19 pandemic. Her primary research focuses on hemostasis disturbances in critical care settings , with expertise in thrombosis biomarkers (D-dimer, fibrin monomer), coagulopathy in viral infections, and blood product optimization for surgical patients. Recent work examines vasopressor effects on renal oxygenation and left ventricular thrombus formation in cardiomyopathies. Her research integrates clinical observations with laboratory hemostasis parameters to improve outcomes in critically ill patients. Analysis of her publication trends reveals a strong emphasis on translational hemostasis research , evolving from COVID-19 coagulopathy studies (2020-2021) to broader surgical complication prevention (2023-2024). Key thematic areas include thrombosis prediction in critical illness, antimicrobial stewardship in viral infections, and cardiac complications in transplantation medicine. Her scholarly impact is reflected in a Scopus h-index of 74 with significant citation metrics, including 38 citations for her seminal work on COVID-19 hemostasis disturbances. Her research has been referenced in clinical guidelines and garnered attention across X (formerly Twitter) with over 100 posts and 148 Mendeley readers. Dr. Michaux maintains active collaborations across European institutions, particularly with University Hospital Center teams. Her current research network focuses on surgical complication prevention, with projects spanning cardiac surgery blood management, lung transplantation outcomes, and critical care nephrology. She contributes to antimicrobial stewardship through surveillance studies of viral infections and hospital epidemiology.

• Hemostasis and Thrombosis
• Critical Care Medicine
• Cardiac Surgery Complications
• +۳ مورد دیگر

Prof. dr. Veerle SOMERS is an Ordinary Professor and Dean of Medicine and Life Sciences at the University of Hasselt. She leads the Department of Immunology & Infection and the Immunology & Infection Research Group within the Biomedical Research Institute. Her research focuses on autoimmune diseases, particularly Multiple Sclerosis (MS), Rheumatoid Arthritis (RA), and Spinal Cord Injury (SCI), with an emphasis on antibody biomarkers and immune mechanisms. She has supervised 18 PhD students and led over 55 research projects. Key areas of investigation include B cell dysfunction in MS, biomarker discovery for early diagnosis, and therapeutic targets in inflammatory diseases. Her work spans clinical and translational research, including studies on immune regulation and patient stratification. Research interests include adaptive immunology, autoimmunity, and musculoskeletal disorders. Recent studies highlight novel antibody biomarkers for predicting therapy response in RA and axSpA, as well as the role of IgD-CD27- B cells in aging and MS progression. She has contributed to clinical trials evaluating treatments like ocrelizumab and dimethyl fumarate, and pioneered studies on photobiomodulation for radiation dermatitis in cancer patients. Prof. SOMERS coordinates courses in genetics, immunology, and biomedical research. Her interdisciplinary approach integrates clinical, molecular, and epidemiological data to advance personalized medicine strategies for autoimmune and neurodegenerative conditions.

• Immunology
• Autoimmune Diseases
• Neuroimmunology
• +۴ مورد دیگر

Prof. Dr. Ir. Benoit STIJLEMANS is a Research Professor at Vrije Universiteit Brussel, where he leads research within the Myeloid Cell Immunology Team. His work focuses on the intricate interactions between host immune responses and parasitic infections, particularly African trypanosomiasis, while also exploring applications in cancer immunology. His educational background includes a Bio-engineering degree in Cell- and Gene biotechnology (1989-1995) followed by a PhD in Applied Biological Sciences (1995-2006) focusing on inflammation-associated anaemia in African trypanosomiasis. He progressed from Post-doctoral assistant (2006-2013) to Senior post-doctoral researcher (2014-2020) before becoming a Research Professor in 2020. Dr. STIJLEMANS' research spans immunology, particularly myeloid cell biology, with emphasis on macrophage function in both infectious disease and cancer contexts. His work bridges fundamental immunological mechanisms with translational applications, especially in nanobody technology development. He has made significant contributions to understanding how parasites like Trypanosoma manipulate host immune responses, particularly through the MIF cytokine family, and how these insights can inform cancer immunotherapy approaches. His research integrates molecular, cellular, and systems-level approaches to dissect complex host-pathogen and tumor-immune interactions. His publication record demonstrates consistent productivity with research spanning from 2002 to the present, with recent work focusing on macrophage plasticity, nanobody applications, and the immunological interface between parasitic infections and cancer biology. Development cooperation prize – edition 2006 Dr. STIJLEMANS has established himself as a leading researcher in myeloid cell immunology, with particular expertise in macrophage biology during parasitic infections and cancer. His work on nanobody technology represents an innovative approach to both diagnostics and therapeutics. The Myeloid Cell Immunology Team he is associated with serves as a hub for interdisciplinary research connecting immunology, parasitology, and cancer biology, fostering collaborations that address fundamental questions while seeking practical applications for disease intervention.

• Immunology
• Myeloid Cell Biology
• Macrophage Biology
• +۶ مورد دیگر

Niels Vandewalle is an active researcher at the Vrije Universiteit Brussel (VUB), affiliated with the Basic (bio-) Medical Sciences department within the Faculty of Medicine and Pharmacy. His work focuses on oncology, immunology, and hematological malignancies, particularly Acute Myeloid Leukemia (AML) and Multiple Myeloma. He leads projects on AXL targeting using single-domain antibodies and small molecule inhibitors, with applications in diagnosis and therapy. Vandewalle has supervised research by Kim De Veirman and collaborates extensively with teams in Belgium and internationally. Research interests include tumor microenvironment dynamics, immune evasion mechanisms, and drug resistance in cancer. His recent studies explore adrenergic signaling's role in myeloma progression and the therapeutic potential of anti-CD40 agonists in activating dendritic cells. Vandewalle has received the Best Poster Presentation award (2024) and contributed to datasets published in high-impact repositories like Zenodo and NCBI GEO. He actively participates in academic events, organizing charity quizzes and PhD symposiums. His projects (e.g., ANI400 and FWOSB110) emphasize translational research, aiming to bridge basic science and clinical applications in leukemia treatment.

• Hematology
• Oncology
• Immunology
• +۶ مورد دیگر

Lennart Martens is a Professor of Systems Biology at Ghent University and serves as Group Leader and Associate Director at the VIB-UGent Center for Medical Biotechnology . He leads the Computational Omics and Systems Biology Group (CompOmics), focusing on Machine Learning applications in high-throughput omics data. His research involves developing AI-driven algorithms for proteomics data analysis, including tools like DeepLC for retention time prediction and MS2Rescore for improved peptide identification. He contributes to open-source proteomics software and FAIR data practices. Fellow of the Royal Society of Chemistry Prometheus Award for Research Excellence (Ghent University, 2014) Juan Pablo Albar 'Proteomics Pioneer' Award (European Proteomics Association, 2015) He has authored over 220 research papers, co-authored two Wiley textbooks on mass spectrometry bioinformatics, and organized Dagstuhl Seminars on computational proteomics. His editorial roles include membership on the boards of Molecular & Cellular Proteomics , Molecular BioSystems , and PeerJ .

• Bioinformatics
• Biomedical Analytics
• Predictive Modelling
• +۵ مورد دیگر